Compared to PD patients without mutations, those with GBA mutations were younger, but had higher Unified Parkinson’s Disease Rating Scale (UPDRS) motor scores for the less affected side despite comparable DAT signals, thus indicating a reduced capacity to cope with PD-related pathology [64]. This evidence concerns the gene SLC6A3 and Parkinson disease.